Drug
Estradiol, Folliculinum, Oophorinum (suis)
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Breast Cancer Female | 113 | 40.7 | 42.8 | signal |
| 2 | Breast Cancer Metastatic | 28 | 25.2 | 25.5 | signal |
| 3 | Product Odour Abnormal | 16 | 14.9 | 15.0 | signal |
| 4 | Breast Cancer | 94 | 9.6 | 10.0 | signal |
| 5 | Middle Insomnia | 16 | 8.3 | 8.4 | signal |
| 6 | Poor Quality Product Administered | 8 | 7.5 | 7.6 | signal |
| 7 | Disease Recurrence | 37 | 7.5 | 7.6 | signal |
| 8 | Squamous Cell Carcinoma | 7 | 7.2 | 7.2 | signal |
| 9 | Tooth Fracture | 8 | 7.0 | 7.0 | signal |
| 10 | Migraine | 63 | 6.4 | 6.6 | signal |
| 11 | Hot Flush | 50 | 6.4 | 6.5 | signal |
| 12 | Brain Neoplasm | 6 | 6.3 | 6.3 | signal |
| 13 | Drug Effect Less Than Expected | 9 | 6.2 | 6.2 | signal |
| 14 | Vaginal Haemorrhage | 27 | 6.1 | 6.2 | signal |
| 15 | Abscess | 10 | 6.0 | 6.1 | signal |
| 16 | Impaired Quality Of Life | 9 | 6.0 | 6.1 | signal |
| 17 | Brain Fog | 9 | 6.0 | 6.0 | signal |
| 18 | Poor Quality Sleep | 13 | 5.9 | 5.9 | signal |
| 19 | Product Availability Issue | 13 | 5.6 | 5.6 | signal |
| 20 | Diverticulitis | 16 | 5.6 | 5.6 | signal |
| 21 | Abnormal Dreams | 16 | 5.6 | 5.6 | signal |
| 22 | Aphonia | 8 | 5.5 | 5.5 | signal |
| 23 | Muscle Twitching | 13 | 5.4 | 5.5 | signal |
| 24 | Blood Pressure Systolic Increased | 11 | 5.4 | 5.4 | signal |
| 25 | Laryngitis | 6 | 5.3 | 5.3 | signal |
| 26 | Retinal Detachment | 5 | 5.2 | 5.3 | signal |
| 27 | Meningioma | 8 | 5.2 | 5.3 | signal |
| 28 | Dysmenorrhoea | 7 | 5.2 | 5.2 | signal |
| 29 | Eye Infection | 6 | 5.2 | 5.2 | signal |
| 30 | Night Sweats | 17 | 5.1 | 5.1 | signal |
| 31 | Hair Texture Abnormal | 7 | 5.0 | 5.0 | signal |
| 32 | Sinus Congestion | 7 | 5.0 | 5.0 | signal |
| 33 | Ankle Fracture | 8 | 5.0 | 5.0 | signal |
| 34 | Ovarian Cyst | 5 | 4.8 | 4.8 | signal |
| 35 | Dry Throat | 5 | 4.7 | 4.8 | signal |
| 36 | Ear Discomfort | 5 | 4.7 | 4.7 | signal |
| 37 | Eructation | 9 | 4.6 | 4.6 | signal |
| 38 | Breast Pain | 5 | 4.5 | 4.5 | signal |
| 39 | Dental Caries | 5 | 4.4 | 4.4 | signal |
| 40 | Rebound Effect | 5 | 4.3 | 4.3 | signal |
| 41 | Respiratory Tract Congestion | 7 | 4.2 | 4.3 | signal |
| 42 | Impaired Driving Ability | 5 | 4.2 | 4.2 | signal |
| 43 | Intentional Dose Omission | 12 | 4.2 | 4.2 | signal |
| 44 | Drug Toxicity | 6 | 4.2 | 4.2 | signal |
| 45 | Muscle Tightness | 7 | 4.2 | 4.2 | signal |
| 46 | Carpal Tunnel Syndrome | 6 | 4.1 | 4.1 | signal |
| 47 | Sedation | 11 | 4.1 | 4.1 | signal |
| 48 | Amenorrhoea | 7 | 4.0 | 4.1 | signal |
| 49 | Feeling Jittery | 8 | 4.0 | 4.1 | signal |
| 50 | Lower Limb Fracture | 8 | 4.0 | 4.1 | signal |
| 51 | Hypokinesia | 6 | 4.0 | 4.0 | signal |
| 52 | Dry Eye | 20 | 4.0 | 4.0 | signal |
| 53 | Crying | 15 | 4.0 | 4.0 | signal |
| 54 | Blood Creatine Phosphokinase Increased | 12 | 4.0 | 4.0 | signal |
| 55 | Covid-19 | 72 | 3.9 | 4.0 | signal |
| 56 | Flatulence | 23 | 3.9 | 3.9 | signal |
| 57 | Device Use Issue | 7 | 3.9 | 3.9 | signal |
| 58 | Heart Rate Irregular | 9 | 3.8 | 3.8 | signal |
| 59 | Hypothermia | 4 | 3.8 | 3.8 | signal |
| 60 | Initial Insomnia | 4 | 3.8 | 3.8 | signal |
| 61 | Mydriasis | 5 | 3.8 | 3.8 | signal |
| 62 | Poor Venous Access | 4 | 3.7 | 3.7 | signal |
| 63 | Injection Site Discomfort | 4 | 3.7 | 3.7 | signal |
| 64 | Needle Issue | 11 | 3.7 | 3.7 | signal |
| 65 | Withdrawal Syndrome | 16 | 3.7 | 3.7 | signal |
| 66 | Mood Swings | 12 | 3.6 | 3.6 | signal |
| 67 | Sars-cov-2 Test Positive | 5 | 3.6 | 3.6 | signal |
| 68 | Thinking Abnormal | 7 | 3.6 | 3.6 | signal |
| 69 | Hunger | 5 | 3.6 | 3.6 | signal |
| 70 | Product Taste Abnormal | 5 | 3.6 | 3.6 | signal |
| 71 | Dysgeusia | 27 | 3.5 | 3.5 | signal |
| 72 | Paranoia | 6 | 3.3 | 3.3 | signal |
| 73 | Hyperthyroidism | 5 | 3.3 | 3.3 | signal |
| 74 | Device Delivery System Issue | 9 | 3.3 | 3.3 | signal |
| 75 | Mood Altered | 9 | 3.2 | 3.2 | signal |
| 76 | Product Substitution Issue | 19 | 3.2 | 3.2 | signal |
| 77 | Tendon Rupture | 4 | 3.1 | 3.1 | no signal |
| 78 | Tooth Extraction | 4 | 3.1 | 3.1 | no signal |
| 79 | Eye Inflammation | 3 | 3.1 | 3.1 | no signal |
| 80 | Injection Site Irritation | 4 | 3.0 | 3.1 | no signal |
| 81 | Incorrect Dose Administered By Device | 8 | 3.0 | 3.0 | signal |
| 82 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 3.0 | 3.0 | signal |
| 83 | Ankylosing Spondylitis | 4 | 3.0 | 3.0 | no signal |
| 84 | Mania | 5 | 2.9 | 2.9 | signal |
| 85 | Influenza Like Illness | 25 | 2.9 | 2.9 | signal |
| 86 | Product Physical Issue | 6 | 2.9 | 2.9 | signal |
| 87 | Psychomotor Hyperactivity | 5 | 2.9 | 2.9 | signal |
| 88 | Activities Of Daily Living Impaired | 6 | 2.9 | 2.9 | signal |
| 89 | Product Prescribing Issue | 6 | 2.8 | 2.8 | signal |
| 90 | Anger | 10 | 2.8 | 2.8 | signal |
| 91 | Colitis Ulcerative | 13 | 2.8 | 2.8 | signal |
| 92 | Hereditary Angioedema | 3 | 2.8 | 2.8 | no signal |
| 93 | Syringe Issue | 5 | 2.8 | 2.8 | no signal |
| 94 | Hepatocellular Injury | 4 | 2.7 | 2.7 | no signal |
| 95 | Eye Irritation | 15 | 2.6 | 2.6 | signal |
| 96 | Suicidal Ideation | 24 | 2.5 | 2.5 | signal |
| 97 | Product Complaint | 6 | 2.3 | 2.3 | no signal |
| 98 | Drug Dose Omission By Device | 18 | 2.3 | 2.3 | signal |
| 99 | Device Mechanical Issue | 3 | 2.2 | 2.2 | no signal |
| 100 | Product Dispensing Error | 5 | 2.2 | 2.2 | no signal |
| 101 | Anorexia | 3 | 2.2 | 2.2 | no signal |
| 102 | Application Site Pain | 5 | 2.2 | 2.2 | no signal |
| 103 | Pain Of Skin | 6 | 2.1 | 2.1 | no signal |
| 104 | Exposure Via Skin Contact | 5 | 2.1 | 2.1 | no signal |
| 105 | Application Site Pruritus | 5 | 2.1 | 2.1 | no signal |
| 106 | Product Administered At Inappropriate Site | 4 | 2.1 | 2.1 | no signal |
| 107 | Therapeutic Response Shortened | 7 | 2.1 | 2.1 | no signal |
| 108 | Wrong Technique In Device Usage Process | 10 | 2.1 | 2.1 | signal |
| 109 | Injection Site Haemorrhage | 17 | 2.1 | 2.1 | signal |
| 110 | Dystonia | 4 | 2.0 | 2.0 | no signal |
| 111 | Glycosylated Haemoglobin Increased | 5 | 1.9 | 1.9 | no signal |
| 112 | Injection Site Pruritus | 13 | 1.9 | 1.9 | no signal |
| 113 | Injection Site Warmth | 4 | 1.9 | 1.9 | no signal |
| 114 | Product Preparation Error | 4 | 1.9 | 1.9 | no signal |
| 115 | Completed Suicide | 16 | 1.8 | 1.8 | no signal |
| 116 | Device Issue | 16 | 1.8 | 1.8 | no signal |
| 117 | Multiple Fractures | 3 | 1.7 | 1.7 | no signal |
| 118 | Injection Site Bruising | 14 | 1.7 | 1.7 | no signal |
| 119 | Complication Of Device Removal | 3 | 1.7 | 1.7 | no signal |
| 120 | Product Adhesion Issue | 6 | 1.6 | 1.6 | no signal |
| 121 | Premature Baby | 5 | 1.6 | 1.6 | no signal |
| 122 | Injection Site Swelling | 12 | 1.5 | 1.5 | no signal |
| 123 | Device Breakage | 6 | 1.5 | 1.5 | no signal |
| 124 | Injury Associated With Device | 3 | 1.4 | 1.4 | no signal |
| 125 | Device Malfunction | 10 | 1.4 | 1.4 | no signal |
| 126 | Device Leakage | 6 | 1.4 | 1.4 | no signal |
| 127 | Injection Site Pain | 43 | 1.4 | 1.4 | no signal |
| 128 | Drug Effective For Unapproved Indication | 4 | 1.3 | 1.3 | no signal |
| 129 | Injection Site Erythema | 16 | 1.2 | 1.3 | no signal |
| 130 | Multiple Sclerosis | 6 | 1.2 | 1.2 | no signal |
| 131 | Drug Withdrawal Syndrome | 11 | 1.2 | 1.2 | no signal |
| 132 | Injection Site Urticaria | 3 | 1.2 | 1.2 | no signal |
| 133 | Device Difficult To Use | 8 | 1.2 | 1.2 | no signal |
| 134 | Product Storage Error | 9 | 1.0 | 1.0 | no signal |
| 135 | Dermatitis Atopic | 5 | 1.0 | 1.0 | no signal |
| 136 | Device Use Error | 3 | 0.8 | 0.8 | no signal |
| 137 | Prostate Cancer | 5 | 0.6 | 0.6 | no signal |
| 138 | Device Expulsion | 3 | 0.4 | 0.4 | no signal |